| Seguin, Philippe |
| Terminated | 2 | 92 | Europe, Japan, US, RoW | BIIB093, Glibenclamide, CIRARA, RP 1127, Placebo | Remedy Pharmaceuticals, Inc. | Brain Contusion | 06/23 | 06/23 | | |
| Not yet recruiting | N/A | 5000 | Europe | questionnaire filling | Centre Hospitalier Universitaire de NÄ«mes | Critical Illness, Covid19, Stress Disorders, Post-Traumatic | 09/22 | 09/22 | | |
| Recruiting | N/A | 770 | Europe | High flow Oxygenation, Standard oxygen | University Hospital, Brest | Chest Trauma, High Flow Oxygenation | 02/26 | 02/26 | | |
NCT02426255: Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA) |
|
|
| Recruiting | N/A | 5000 | Europe | Collection of medical data from ICU patients | Nantes University Hospital | Severe Trauma (With or Without Traumatic Brain Injury) | 01/50 | 01/50 | | |
| Gandemer, Virginie |
CAALL-F01, NCT02716233: A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescents |
|
|
| Recruiting | 3 | 1578 | Europe | pegaspargase 1250 IU/m2 x 2, ONCASPAR 1250 IU/m2 x 2, pegaspargase 2500 IU/m2 x 1, ONCASPAR 2500 IU/m2 x 1 | Assistance Publique - Hôpitaux de Paris, Shire | Acute Lymphoblastic Leukemia | 04/26 | 04/26 | | |
TAK-620-2004, NCT05319353 / 2021-004279-15: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT) |
|
|
| Active, not recruiting | 3 | 80 | Europe, Japan, US, RoW | Maribavir, TAK-620 | Takeda, Takeda Development Center Americas, Inc. | Cytomegalovirus (CMV) | 01/27 | 01/27 | | |
| Recruiting | 3 | 6430 | Europe, RoW | Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto | Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins | Leukemia, Acute Lymphoblastic | 06/27 | 06/32 | | |
| Recruiting | 2/3 | 1800 | Europe, Canada, RoW | VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin | St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group | Acute Lymphoblastic Leukaemia | 06/25 | 04/30 | | |
HAPLO-EMPTY, NCT05126849: Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression |
|
|
| Recruiting | 2 | 31 | Europe | Allogenic transplantation | Assistance Publique - Hôpitaux de Paris | Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation | 01/27 | 01/27 | | |
NCT04501614 / 2019-002549-39: A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia |
|
|
| Terminated | 1/2 | 11 | Europe, US, RoW | Ponatinib, Chemotherapy Agents | Takeda, Takeda Development Center Americas, Inc. | Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL), Philadelphia Chromosome-Like ALL (Ph-like ALL) | 12/23 | 07/24 | | |
NCT02938858: French Registry of First-line Treatment of Acute Promyelocytic Leukemia |
|
|
| Recruiting | N/A | 400 | Europe | | Groupe Francophone des Myelodysplasies, Teva Pharmaceuticals USA | Acute Promyelocytic Leukemia | 10/20 | 10/22 | | |
| Recruiting | N/A | 16 | Europe, Japan, US, RoW | genetic restrospective study | Institut National de la Santé Et de la Recherche Médicale, France | Immune Deficiency, Autoimmune Diseases, Infections, Diagnosis | 08/26 | 01/27 | | |
| Not yet recruiting | N/A | 50 | Europe | Sampling bone tissue and blood | Rennes University Hospital | Leukemia, Lymphoblastic, Acute, Pediatric | 02/35 | 06/35 | | |
ALARM3, NCT05772559: Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies |
|
|
| Recruiting | N/A | 500 | Europe | Collection of blood sample of bone marrow (cohort 1), Collection of blood sample of bone marrow (cohort 2 and 3) | Assistance Publique - Hôpitaux de Paris | Acute Myeloid Leukemia, Genetic Predisposition to Disease | 05/33 | 05/33 | | |
GATA-2, NCT05983991: Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline Mutation |
|
|
| Recruiting | N/A | 150 | Europe | Biological samples (blood and bone marrow samples). | Institut Claudius Regaud | GATA2 Gene Mutation | 10/33 | 10/33 | | |
| MAHE, Guillaume |
VIRTUOSE, NCT03686306: : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. |
|
|
| Recruiting | 3 | 220 | Europe | Sildenafil, Placebo | Rennes University Hospital | Peripheral Artery Disease | 11/24 | 06/25 | | |
| Enrolling by invitation | N/A | 1000 | Europe | Doppler arterial waveforms analysis | Rennes University Hospital, French Society of Vascular Medicine | French Vascular Physicians | 12/22 | 12/22 | | |
| Moirand, Romain |
ADALOB, NCT04626570: Impact of a Phone-based Cognitive and Behavioral Therapy on Food Addiction in Patients With Severe or Morbid Obesity |
|
|
| Recruiting | N/A | 154 | Europe | Cognitive and Behavioral Therapy | University Hospital, Tours | Obesity, Food Addiction | 04/24 | 01/25 | | |
CliniCAP, NCT06616064: Evaluation of a Procedure for Identification and Brief Intervention of Lifestyle Advice Assisted by Application in a Care Setting |
|
|
| Not yet recruiting | N/A | 148 | Europe | personalised feedback and brief motivational, routine lifestyle advice, questionnaire CliniCAP | Rennes University Hospital | Chronic Disease | 10/25 | 10/26 | | |
| Recruiting | N/A | 720 | Europe | Post-transplant addiction intervention | University Hospital, Montpellier | Alcohol Associated Liver Disease, Liver Transplantation | 09/26 | 09/28 | | |
Cemov, NCT05200182: fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating |
|
|
| Recruiting | N/A | 80 | Europe | Neurofeedback with functional near infra-red spectroscopy, Sham Neurofeedback, oral microbiota collection, Questionnaires, resting-state fMRI, Electro gastrogram, Emotional Stroop task | Rennes University Hospital, Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement | Hyperphagia | 05/25 | 05/25 | | |
| Withdrawn | N/A | 60 | NA | Induction of alcohol craving, Questionnaires | Rennes University Hospital | Alcoholism, Alcohol Dependence | 05/25 | 11/25 | | |
| Beloeil, Helene |
SMART ANGEL 2, NCT04068584: Evaluation of the Impact of the SMART ANGEL â„¢ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery |
|
|
| Recruiting | N/A | 1260 | Europe | Smart Angel | Centre Hospitalier Universitaire de NÄ«mes, EVOLUCARE | Ambulatory Surgery | 08/22 | 08/22 | | |
| Lassel, Linda |
PREGRALL, NCT03183440: Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old Children |
|
|
| Recruiting | N/A | 376 | Europe | PREBIOTICS, PLACEBO | Nantes University Hospital | Dermatitis, Atopic | 08/23 | 08/23 | | |
| Recruiting | N/A | 322 | Europe | | University Hospital, Brest | Cholestasis of Pregnancy | 06/25 | 06/25 | | |
| LEBOUVIER, Thomas |
| Completed | 3 | 700 | Europe | Inhaled sedation with sevoflurane, intravenous sedation with propofol | University Hospital, Clermont-Ferrand | Acute Respiratory Distress Syndrome | 10/23 | 10/24 | | |
| Recruiting | N/A | 770 | Europe | High flow Oxygenation, Standard oxygen | University Hospital, Brest | Chest Trauma, High Flow Oxygenation | 02/26 | 02/26 | | |
| PAINVAIN, Benoit |
XPRESSE, NCT04950270: Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome |
|
|
| Completed | N/A | 24 | Europe | Blood copeptin monitoring, phone interview | University Hospital, Tours | Posterior Reversible Encephalopathy Syndrome | 02/24 | 02/24 | | |
| DELAMAIRE, Flora |
NCT06596096: Risk Factors for Beta-lactam Target Non Attainment in Critically Ill Patients BETALACTACRIT |
|
|
| Recruiting | N/A | 300 | Europe | | Centre Hospitalier de Saint-Brieuc | Sepsis | 06/25 | 07/25 | | |
XPRESSE, NCT04950270: Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome |
|
|
| Completed | N/A | 24 | Europe | Blood copeptin monitoring, phone interview | University Hospital, Tours | Posterior Reversible Encephalopathy Syndrome | 02/24 | 02/24 | | |
